Table 2.
No. | Compound(s)/Extract(s) Used | Subjects Used | Duration | Treatment Method | Results | Ref. |
---|---|---|---|---|---|---|
1 | Green tea polyphenols | 12 human volunteers between 18–65 years | 3 months | Consume capsules of green tea polyphenols | Conjugate metabolites in plasma, blister fluid, and skin biopsy samples | [89] |
2 | Green tea extract | 18 human volunteers between 21 and 71 | 34 days | Topical application | Reduction in the level of cells with sunburn | [90] |
3 | Green tea extract | Human volunteers aged between 18 and 50 | - | Topical application ranging from 0.25 to 10% Topical applicationof 5% EGCG, EC, and EGC |
Decreased sunburn cells by 66% 0.5 to 2.5% concentration showed optimum activity Lesser activity when compared to the crude extracts |
[91] |
4 | Green tea extract | 10 human volunteers | 15 min prior to UV irradiation and immediately after exposure | Topical application | Lesser DNA damage when compared to vehicle control | [92] |
5 | Green tea extract | 20 Chinese women | 30 min prior to UV irradiation and 6, 24, and 48 h after exposure | Topical application (2–5%) | 3% of topical application showed less erythema, mild pigmentation, controlled level of thickening of stratum corneum and epidermis, and reduction of matrix metalloproteases | [93] |
6 | Green tea extract | 42 Korean females | 8 weeks | Topical application at crow’s feet | Free radical scavenging and antiwrinkle effects | [94,95] |
7 | Green tea polyphenols | 56 women aged 25 to 75 | 2 years | Oral supplements of 250 mg green tea polyphenols | Improvement in facial skin and in controlling erythema | [96] |
8 | Green tea extract | 2015 subjects aged over 65 years | 6 months | Oral consumption | Reduced the prevalence of Alzheimer’s disease and cognitive impairment | [171] |
epicatechin (EC); epigallocatechin (EGC).